「KRAS Inhibitor Resistance in MET-Amplified KRAS G12C Non–Small Cell Lung Cancer Induced By RAS- and Non–RAS-Mediated Cell Signaling Mechanisms」の関連論文
-
Profiling of Naquotinib, a Small Molecule Kinase Inhibitor, as EGFR and BTK Inhibitor
-
Inhibition of EGFR and MEK surmounts entrectinib resistance in a brain metastasis model of NTRK1-rearranged tumor cells
-
Studies on the Enhancement of Antitumor Effect by Drug Combination in Molecular-Targeted Therapy of Cancer
-
An HSP90 inhibitor overcomes EGFR amplification-induced resistance to third-generation EGFR-TKIs
-
Neoadjuvant chemotherapy promotes the expression of HER3 in patients with ovarian cancer
-
Paradoxical activation of c-Src as a drug-resistant mechanism
-
Antitumor Activity of the Novel Oral Heat Shock Protein 90 Inhibitor in Mono Therapy and Combination Therapy
-
JNK and Yorkie drive tumor malignancy by inducing L-amino acid transporter 1 in Drosophila
-
Yes-associated protein 1 mediates initial cell survival during lorlatinib treatment through AKT signaling in ROS1-rearranged lung cancer
-
Efficacious Combination Drug Treatment for Colorectal Cancer that Overcomes Resistance to KRAS G12C Inhibitors
-
肺がん細胞の senolysis とferroptosis において 細胞質 p21Cip1/Waf1 は防御的に作用する
-
Brg1 is required to maintain colorectal cancer stem cells
-
Dual blockade of macropinocytosis and asparagine bioavailability shows synergistic anti-tumor effects on KRAS-mutant colorectal cancer
-
卵巣低異型度漿液性癌のin vitro発癌モデル
-
Transposon delivery for CRISPR-based loss-of-function screen in mice identifies NF2 as a cooperating gene involved with the canonical WNT signaling molecular class of hepatocellular carcinoma
-
Chemosensitivity of Patient-Derived Cancer Stem Cells Identifies Colorectal Cancer Patients with Potential Benefit from FGFR Inhibitor Therapy
-
SPC18 expression is an independent prognostic indicator of patients with esophageal squamous cell carcinoma
-
SPC18 expression is an independent prognostic indicator of patients with esophageal squamous cell carcinoma
-
Roles of non-canonical phosphorylation in negative feedback regulation and intracellular trafficking of oncogenic EGFRvIII in glioblastoma cells
-
Inhibition of heat shock protein 90 destabilizes receptor tyrosine kinase ROR1 in lung adenocarcinoma
-
Systemic therapy for salivary gland malignancy: current status and future perspectives
-
The clinical significance of CXCL16 in the treatment of advanced non-small cell lung cancer
-
Study of the Effects of Inhibition of Epigenetic Regulators on the Proliferation of Hematological Malignant Tumor Cells
-
Studies on Cytotoxic Effects of Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL) to Canine Cell Lines Derived from Hemangiosarcoma and Mammary Epithelial Tumor
-
Activation of BAX and BAK is an attractive combination therapy in melanoma
-
Suppression of malignant rhabdoid tumors through Chb-M′-mediated RUNX1 inhibition
-
Antioxidants and Therapeutic Targets in Ovarian Clear Cell Carcinoma.
-
Distinctive roles of syntaxin binding protein 4 and its action target, TP63, in lung squamous cell carcinoma: a theranostic study for the precision medicine
-
An Oncogenic Alteration Creates a Microenvironment that Promotes Tumor Progression by Conferring a Metabolic Advantage to Regulatory T Cells
-
Nrf2/p-Fyn/ABCB1 axis accompanied by p-Fyn nuclear accumulation plays pivotal roles in vinorelbine resistance in non-small cell lung cancer
-
Neutrophil Extracellular Traps Promote Metastases of Colorectal Cancers through Activation of ERK Signaling by Releasing Neutrophil Elastase
-
Stromal reaction inhibitor and immune-checkpoint inhibitor combination therapy attenuates excluded-type colorectal cancer in a mouse model
-
Stromal reaction inhibitor and immune-checkpoint inhibitor combination therapy attenuates excluded-type colorectal cancer in a mouse model
-
Nucleolar stress: Molecular mechanisms and related human diseases
-
De Novo T790M Mutation in an L858R Epidermal Growth Factor Receptor Mutant-Associated Lung Adenocarcinoma
-
Lusutrombopag effectively promotes the growth and differentiation of megakaryocytic cells from patients with myelodysplastic syndrome
-
Clinicopathological significance of intelectin-1 in colorectal cancer: Intelectin-1 participates in tumor suppression and favorable progress
-
Clinicopathological significance of intelectin-1 in colorectal cancer: Intelectin-1 participates in tumor suppression and favorable progress
-
Mechanisms of anti-inflammatory and anticancer effects of biologically active components of cinobufacini
-
Identification of the ultrahigh-risk subgroup in neuroblastoma cases through DNA methylation analysis and its treatment exploiting cancer metabolism
-
Blockade of EGFR improves responsiveness to PD-1 blockade in EGFR-mutated non–small cell lung cancer
-
Development of a novel cancer therapy with a ferroptosis inducer and radiation, and a prediction method for therapeutic effects targeting ferroptosis
-
Functional analysis of mitochondria-mediated ovarian carcinoma immune-reactive antigen domain 2 in lung adenocarcinoma
-
MicroRNA profiles following telmisartan treatment in pancreatic ductal adenocarcinoma cells
-
The Roles of Cancer-Associated Fibroblasts in Colorectal Carcinogenesis
-
FXYD3 functionally demarcates an ancestral breast cancer stem cell subpopulation with features of drug-tolerant persisters
-
The Effect of Diabetic Medicine Exendin-4 on Lipopolysaccharide-induced Bone Resorption, Osteoclast Formation, and Orthodontic Tooth Movement
-
Analyses of the Molecular Determinant of Cell Fate Induced by an Antimetabolite, Trifluridine
-
Characterization of the Anticancer Activities of Some Natural and Synthetic Compounds: Molecular Targets and Mechanism
-
The therapeutic potential of multiclonal tumoricidal T cells derived from tumor infiltrating lymphocyte-derived iPS cells